Instead of focusing on the activity patterns of individual muscles, the neuromuscular control of motor tasks can be described by muscle synergies, [8] [9] [10] A muscle synergy is a group of muscles that are recruited simultaneously (ie co-activated) with distinct relative levels of activation. The central nervous system (CNS) is presumed to produce movements not by activating individual muscles, but by activating muscle synergies. [8] [9] [10] In healthy individuals, it has been shown that a large part (>90%) of the variance in muscle activity during gait can be described by a limited number (4-5) of muscle synergies. 11, 12 The same approach has been applied in several neurological diseases (ie cerebral palsy, Parkinson, stroke and incomplete spinal cord injury). Patients were found to use a lower number of muscle synergies and altered structure of the synergies, which was related to functional and clinical assessments. [13] [14] [15] [16] A lower number of synergies is interpreted as a more simplified (ie decreased complexity)
control by the CNS. When applied in musculoskeletal diseases (ie sacroiliac joint pain, anterior cruciate ligament-deficient, gluteal tendinopathy), also a different synergy structure compared to a control group was observed, but no difference in the number of muscle synergies. [17] [18] [19] Recently, a new measure has been proposed called the Walking Dynamic Motor Control Index (Walk-DMC), which is based on the total EMG variance explained by one synergy. 15 The Walk-DMC has been proposed as a potential metric to assess the complexity of motor control and was shown to be associated with clinical outcomes after conservative treatment and orthopaedic surgery in patients with cerebral palsy. 15, 20, 21 Applying measures of complexity of neuromuscular control may also be a valuable clinical tool to assess the level of neuromuscular impairment in PWHA with different levels of joint damage.
The aims of this study are as follows: (a) to assess how haemophilic arthropathy affects the complexity of neuromuscular control during gait, (b) to investigate the relationship between complexity of neuromuscular control and joint impairment.
| MATERIAL AND ME THODS

| Participants
This study was approved by the local ethical committee and conducted in agreement with the Declaration of Helsinki. All participants were informed about the purpose and procedures of the project and gave their written informed consent to participate in the study. Based on non-probability sampling, thirteen PWHA were recruited in two hospitals in Santiago (Chile), and thirteen healthy control subjects (student and employees) were recruited from the University of Chile (for their characteristics see Table 1 ). 
| Data acquisition
In PWHA, the limb with the highest score on the HJHS was selected.
In the control group (CG), the dominant limb was assessed, which was determined by asking the subjects which leg they would use to kick a ball. 22 After shaving and cleaning the skin with alcohol, surface elec- 
| Experimental protocol
To assess if subjects had a sedentary lifestyle (<150 minutes per week of moderate physical activity), they were asked to indicate how many minutes per week they were involved in physical activity. 24 Each subject was invited to walk barefoot overground at their preferred velocity and the CG also walked at a slower velocity similar to that of the mean preferred velocity in PWHA (1.0 m/s). Each TA B L E 2 Equations used for the muscle coordination analysis Index Equations
The total variance accounted for (tVAF). tVAF by one synergy (tVAF1).
Original EMG data (EMGo). Reconstructed EMG data (EMGr). Dynamic motor control index (Walk-DMC). Average (AVGc) and standard deviation (SDc) of tVAF1 from the control group.
F I G U R E 1 EMG activity patterns of multiple muscles during gait. A, Example of one healthy individual (black). EMG activity patterns during gait of two people with haemophilic arthropathy (PWHA) (red). B, Example of PWHA with low HJHS score in both knee and ankle (knee = 0 points; ankle = 2 points). C, Example of PWHA with high HJHS score in both knee and ankle (knee = 8 points; ankle = 8 points). The data show 20 gait cycles during slow velocity walking for the healthy subject (1.2 m/s) and the preferred velocity of the haemophilic patients (1.24 m/s and 1.03 m/s, respectively). Note that in PWHA, the EMG activity patterns of several muscles are similar indicating a high degree of co-activation between flexion and extension muscles. In the PWHA with high HJHS score (C), more than 80% of variance of all muscles can be explained by one synergy, while in the healthy subject one synergy explains only 54% of the variance. This can be explained by more co-activation between flexion and extension muscles and has been interpreted as an indication of more simplified control by the central nervous system. a.u., Arbitrary unit; BF, Biceps Femoris; GMAX, Gluteus Maximus; GMED, Gluteus Medius; LG, Lateral Gastrocnemius, MG, Medial Gastrocnemius; RF, Rectus Femoris; TA, Tibialis Anterior; SOL, Soleus; ST, Semitendinosus; VL, Vastus Lateralis; VM, Medialis. The total variance accounted for one synergy (tVAF1). The dynamic motor control index (Walk-DMC) velocity was practiced three times for 10 m. Mean velocity was assessed by dividing total distance by total time. Subsequently, each subject walked barefoot for 30-m, two times in each velocity, with 2 minutes of rest in between tests. Between 1 and 2 hours prior to the experiment, patients received prophylactic treatment.
| EMG data analysis
For the EMG and synergies analysis, Matlab software was used (MathWorks, Inc, Natick, MA, USA). For each condition in each group, 20 gait cycles were included for the analysis.
A bandpass filter (20-500 Hz) followed by rectification using
Hilbert transformation was applied. Subsequently, EMG signals were low-pass filtered at 10 Hz and per condition normalized to the maximum value of all included cycles. 25, 26 Then, EMG data was time normalized to 200 points. 25 Non-negative matrix factorization (NNMF) was used to extract muscle synergies from the EMG signals (for a comprehensive description see 27 ). Briefly, the EMGs were combined into an m × t matrix, where m represents the number of muscles (11 in this study) and cycles (20 cycles), and t is the time base (200 points). The NMMF results in the muscle weightings (ie contribution)
for each synergy (W) and the matrix encoding the activation pattern of each synergy (C). Note that the product of W and C should approximate the original EMG data.
The NNMF algorithm was iterated 20 times for each number of synergies between 1 and 4, and the iteration with the lowest reconstruction error was selected. The difference between reconstruction of EMG data and the original EMG data was calculated using the total variance accounted for (tVAF) ( Table 2, Equation   1 ). 13 The tVAF was calculated for an increasing number of synergies (from 1 to 4). The number of synergies was increased until tVAF was >90% or until adding another synergy did increase tVAF by <5%. 13 We used three measures to evaluate complexity of neuromuscular control: 15, 28 (a) the number of synergies required for tVAF > 90%, (b) tVAF as a function of the number of muscle synergies and (c)
Walk-DMC index. The Walk-DMC is a z-score based upon tVAF1, using the average and standard deviation of tVAF1 from the healthy CG (Table 2, Equation 2 ). 15 A higher tVAF1 results in a lower Walk-DMC score (see Figure 1 ).
| Clinical assessments for PWHA
To assess the intensity of pain (scale 0-10 points) during walking barefoot, the Visual Analogue Scale (VAS) was applied. The HJHS 2.1 score is used to assess joint health status in both knees and ankles. 
| RE SULTS
| Anthropometric and clinical characteristics
| Neuromuscular control
The number of muscle synergies for tVAF > 90% was not different between groups (ie median of four synergies, range 3-4 for CG-pref, 3-5 for CG-slow and 3-5 for PWHA), both when compared at preferred walking velocity (P = 0.698) and when compared at similar velocity (P = 0.540).
Comparing groups at their preferred velocity (Figure 2 ), twoway repeated measures ANOVA indicated a significant difference between groups (P = 0.020, The consequence of these results is increased co-activation between antagonistic and synergistic muscles.
| Cluster analysis of HJHS of knee and ankle and Walk-DMC index
The k-means cluster analysis for the HJHS score resulted in two clusters. The silhouette value was 0.74 ± 0.12 for cluster 1 and 0.68 ± 0.06 points for cluster 2 ( Figure 5A ). Cluster 1 is characterized by a low HJHS score in the knee and cluster 2 by a high HJHS value in the knee ( Figure 5B ). The pain level and velocity during gait were similar between clusters (P > 0.05) ( Table 3) .
When compared at the similar velocity, one-way ANOVA revealed a significant group effect on Walk-DMC (P = 0.019, 
| D ISCUSS I ON
The main results of this study are as follows: (a) that on average the complexity of neuromuscular control (ie the extent of muscle co-activation) during gait in PWHA was different from healthy controls; and (b) that the complexity of neuromuscular control (Walk-DMC) F I G U R E 2 The total variance accounted for (tVAF) by one to four muscle synergies. A comparison between the control group (CG) during walking at the preferred (CG-pref) and at the slow (CG-slow) velocity and people with haemophilic arthropathy (PWHA) during walking at preferred velocity is shown. *P < 0.05 significant difference between CG and PWHA. Data are expressed as mean and 95% confidence intervals (n = 13 for both groups) F I G U R E 3 Dynamic Motor Control Index during Walking (Walk-DMC). A comparison between the control group during preferred (CG-pref) and slow walking velocity (CG-slow) and people with haemophilic arthropathy (PWHA) during preferred walking velocity. Blue horizontal dashed line indicates the normal value of Walk-DMC. Black horizontal dashed line indicates the 80 points of Walk-DMC, which is equal to two standard deviations (SD) from the normal value. *P < 0.05 significant difference between groups. The open circles indicate the individual data. Data are expressed as mean and 95% confidence intervals (n = 13 for both groups)
was not correlated with ankle and knee joint health status (HJHS).
To the authors' current knowledge, this study is the first to suggest an increased co-activation between synergistic and antagonistic muscles during gait in PWHA. This is clinically relevant, because a greater co-activation between antagonistic muscles could result in more intra-articular loading, resulting in greater progression of the osteoarthritis. 31 The number of muscle synergies for tVAF > 90% in PHWA was not different than that in the CG. This is in agreement with previous reports on effects of musculoskeletal diseases. [17] [18] [19] In contrast, several studies have reported a lower number of muscle synergies in neurological diseases. 12, 13 As the number of synergies is not a very distinctive measure, we also assessed other metrics of the complexity of neuromuscular control. We found significant For tVAF1, the mean difference between PWHA and CG was more than 7%. This difference between groups is higher than inter-day measurement error of the tVAF1 reported for patients with cerebral palsy (ie 5%). 21 At the individual level, there was quite some overlap of Walk-DMC values between the two clusters for PWHA and CG. This suggests that some PWHA have normal neuromuscular control of gait.
The higher tVAF1 and lower Walk-DMC in PHWA can be explained by more co-activation of synergists and antagonists (see Figure 1 ). This is supported the increased co-activation of knee flexors and extensors during acceptance and push-off synergies (see Figure 4 ). Both results have been interpreted as indications of more simplified control by the CNS during gait.
13,15
The z-score normalization of tVAF1 (ie Walk-DMC) has some advantages compared to the tVAF1. It is affected less by the different methods of EMG processing and it can be better compared across studies. 20 The observed changes in neuromuscular control may be ex- change the kinematics and kinetics of gait. 33 However, the pain levels during walking in the PWHA of the present study were rather low (see Table 1 and 2). Therefore, we do not expect pain to play an im- that static balance control is affected in PWHA. 35, 36 The enhanced co-activation between flexors and extensors during gait, increasing joint stiffness, could be related to the reduced proprioception and impaired postural control. 37, 38 In the clinical context, the tVAF1 and Walk-DMC may be of additive value to assess the quality of neuromuscular control. Different approaches have been reported to enhance muscle function and joint range of motion, and reduce pain in PWHA. 39 However, in PWHA little is known about the impact of physical therapy on neuromuscular control. The selection of the best exercise protocol to reduce the extent of co-activation between joint flexor and extensor muscles could be relevant to prevent joint deterioration. 31, 33, 37 This TA B L E 3 Clinical characteristic between clusters in PWHA may help to improve solutions for rehabilitation after conservative treatment and orthopaedic surgery. 39, 40 A limitation of this study is that joint kinematics and kinetics were not assessed. Therefore, it is unclear if the gait movement pattern and mechanics were different in PWHA, and if this was related to the changes in neuromuscular control. In addition, a thorough analysis of the relationship between joint structure, muscle dysfunction and neuromuscular control is warranted, by adding radiological exams such as computed tomography, magnetic resonance imaging and sonography.
| CON CLUS ION
The complexity of neuromuscular control during gait was reduced in PWHA by means of increased co-activation between synergistic and antagonistic muscles. Our results indicate that neuromuscular control is affected more in PWHA with multi-joint damage compared to single joint damage. The tVAF1 and Walk-DMC may be useful measures to assess changes in neuromuscular control in PWHA before and after rehabilitation therapies and or orthopaedic surgical interventions.
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